Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase igf1r'

Search results for: 'research area tyrosine kinase igf1r'

Items 201-210 of 284

Page
per page
  1. A-674563
    A8616 A-674563
    Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK
    Summary: Akt1/PKA/CDK2 inhibitor,potent and selective
      insoluble in EtOH; ≥23.8 mg/mL
  2. K145
    B1298 K145
    Target: Sphingosine kinases (SphKs)
    Summary: SphK2 inhibitor
      Soluble in DMSO
  3. BIX 02565
    B1295 BIX 02565
    Target: S6 kinases
    Summary: RSK2 inhibitor
      ≥22.95 mg/mL
  4. SMI-4a
    A4193 SMI-4a
    Target: Pim
    Summary: Potent Pim inhibitor
      insoluble in H2O; ≥13.65 mg/mL
  5. SB 216763
    A8240 SB 216763
     3 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor,ATP-competitive,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥56.8 mg/mL
  6. 3-Methyladenine
    A8353 3-Methyladenine
     3 Citation
    Target: PI3K
    Summary: Class III PI3K inhibitor
      ≥5 mg/mL
  7. Poloxin
    A3732 Poloxin
    Target: PLK
    Summary: PLK1 inhibitor
      insoluble in H2O; ≥14.85 mg/mL
  8. CZC-25146
    B4635 CZC-25146
    Target: LRRK2
    Summary: LRRK2 inhibitor
      ≥24.45 mg/mL
  9. BMS 309403
    B7794 BMS 309403
     2 Citation
    Target: Fatty-acid-binding proteins (FABPs)
    Summary: FABP4 inhibitor,potent and selective
      insoluble in H2O; ≥18.15 mg/mL
  10. LY364947
    B2287 LY364947
     1 Citation
    Summary: inhibitor of TGF-β type I receptor kinase domain
      insoluble in EtOH; insoluble in H2O; ≥24.4 mg/mL

Items 201-210 of 284

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 281item
  2. Natural Products 1 item
  3. Lab Reagents 1 item
Specificity
  1. Selective 211item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 22item
  2. Irreversible 6item
Target
  1. Cyclin-Dependent Kinases 22item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 4item
  4. PI3K 14item
  5. Raf 10item
  6. Aurora Kinases 18item
  7. CSF-1R 4item
  8. mTOR 7item
  9. FLT3 13item
  10. GSK-3 8item
  11. PLK 6item
  12. Chk 5item
  13. Eph Receptors 2item
  14. VEGFR 30item
  15. PDGFR 22item
  16. c-Kit 12item
  17. RET 4item
  18. IRAK 1 item
  19. Bromodomain-containing proteins(BRDs) 1 item
  20. p38 6item
  21. PKB 1 item
  22. JNK 1 item
  23. SGK 1 item
  24. Bcr-Abl 11item
  25. MEK 3item
  26. FGFR 12item
  27. Insulin-like growth factor receptors(IGFRs) 1 item
  28. Pim 3item
  29. Voltage-gated Sodium (NaV) Channels 1 item
  30. MET 5item
  31. Src 14item
  32. Trk Receptors 2item
  33. STAT 3item
  34. EGFR 16item
  35. ROCK 5item
  36. BTK 1 item
  37. PAK 3item
  38. FAK 4item
  39. BMP and Other Activin Receptors 2item
  40. JAK 14item
  41. Syk 5item
  42. DNA-PK 4item
  43. AMPK 2item
  44. PDHK 1 item
  45. Cytochrome P450 (CYP450) 1 item
  46. ErbB 4item
  47. S6 kinases 1 item
  48. Adenosine Kinases 2item
  49. ERK 4item
  50. c-MET 5item
  51. PKC 11item
  52. Ubiquitin-specific proteases 1 item
  53. Ca2 /calmodulin-dependent protein kinases (CaMKs) 5item
  54. Lyn 2item
  55. HER2 2item
  56. Pyk2 3item
  57. LRRK2 5item
  58. Insulin and Insulin-like Receptors 3item
  59. ALK 6item
  60. ROS1 1 item
  61. Sphingosine kinases (SphKs) 2item
  62. PKG 1 item
  63. PKA 4item
  64. Myosin light chain kinases (MLCKs) 1 item
  65. MELK 1 item
  66. Insulin-like growth factors (IGFs) 1 item
  67. MK2 2item
  68. Fatty-acid-binding proteins (FABPs) 1 item
  69. Angiotensin-Converting Enzymes (ACEs) 1 item
  70. Tie-2 2item
  71. RSK 2item
  72. phosphatases 1 item
  73. ATM/ATR 2item
  74. Farnesyl Diphosphate Synthases 1 item
  75. CK2 2item
  76. HIPK2 1 item
  77. HIPK3 1 item
  78. P2X Receptors 1 item
  79. Histamine H1 Receptors 1 item
  80. P110 1 item
  81. Hck 2item
  82. MNK 1 item
  83. 5-Lipoxygenases 1 item
  84. Insulin Receptors 1 item
  85. IRG-1R 1 item
  86. Cdc2-like kinase (Clk) 1 item
  87. eEF-2 1 item
  88. Cdc7 1 item
  89. ZAP-70 1 item
  90. c-RET 3item
  91. p70 rsk 2item
  92. VEGFR3/FLT4 1 item
  93. NTRK1/TRKA 1 item
  94. CSF-1R/c-Fms 1 item
  95. TAM kinase 1 item
  96. KDR 1 item
  97. Fyn kinase 1 item
  98. AXL 1 item
  99. c-Fms tyrosine kinase 1 item
  100. insulin 1 item
  101. MSK 1 item
  102. Lyn kinase 1 item
  103. Mer tyrosine kinase 1 item
  104. ErbB-2 1 item
  105. PDK-1 1 item
  106. Histone Acetyltransferases (HATs) 1 item
  107. Prk 1 item
  108. ITK 1 item
  109. NUAK 1 item
  110. DCLK2 1 item
  111. PTK 1 item
  112. phosphatidylinositol kinase 1 item
  113. Flk1 2item
  114. Protein Tyrosine Phosphatases 1 item
  115. alkaline phosphatases 1 item
  116. ATPases 1 item
  117. glutamate release 1 item
  118. FGR 1 item
  119. YES 2item
  120. Fyn 2item
  121. ARG 1 item
  122. TRPC channel 1 item
  123. PKD 1 item
  124. Pyruvate kinases 1 item
  125. enoyl-acyl-carrier protein reductase 1 item
  126. Rho-kinase 1 item
  127. tropomyosin receptor kinase 1 item
  128. SK 1 item
  129. PPK 1 item
  130. c-Syk 1 item
  131. CDK1/CyclinB 1 item
  132. PIM1 kinase 1 item
  133. phospholipase A2 1 item
  134. PIKfyve 1 item
  135. Insulin Receptor 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 15item
  3. Adrenocortical Carcinoma 2item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 4item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 42item
  9. Cancer 185item
  10. Cervical Cancer 4item
  11. Cholangiocarcinoma 2item
  12. Chronic Lymphocytic Leukemia 2item
  13. Clear Cell Renal Cell Carcinoma 1 item
  14. Colon Cancer 18item
  15. Colon Carcinoma 3item
  16. Colorectal Cancer 18item
  17. Glioblastoma 17item
  18. Glioma 6item
  19. Hepatocellular Carcinoma 4item
  20. HIV Infections 1 item
  21. Immunological Diseases 1 item
  22. Inflammatory Bowel Disease 1 item
  23. Inflammatory Diseases 3item
  24. Leukemia 8item
  25. Liver Cancer 3item
  26. Lung Cancer 14item
  27. Lung Carcinoma 3item
  28. Lymphoma 9item
  29. Mantle Cell Lymphoma 1 item
  30. Melanoma 11item
  31. Multiple Myeloma 4item
  32. Myelofibrosis 1 item
  33. Myeloma 2item
  34. Neuroblastoma 2item
  35. Non-small Cell Lung Cancer 6item
  36. Non-small Cell Lung Carcinoma 1 item
  37. Ovarian Cancer 14item
  38. Pancreatic Cancer 22item
  39. Prostate Cancer 14item
  40. Psoriasis 1 item
  41. Pulmonary Arterial Hypertension 1 item
  42. Renal Cancer 3item
  43. Renal Cell Carcinoma 5item
  44. Rheumatoid Arthritis 5item
  45. Thyroid Cancer 5item
  46. Type 2 Diabetes 3item